Evidence for essential lysines in heparin cofactor II.
Covalent modification with pyridoxal 5'-phosphate was used to study the function of lysyl residues in heparin cofactor II, a heparin-dependent plasma protease inhibitor. Reduction of the Schiff base with sodium borohydride resulted in modification of 3-4 lysyl residues of heparin cofactor II at high concentrations of pyridoxal 5'-phosphate, one of which was protected in the presence of heparin. The antithrombin activity of modified heparin cofactor II was enhanced compared to the native protein. However, the heparin cofactor activity for thrombin inhibition was reduced significantly or completely eliminated in the modified protease inhibitor depending on the extent of phosphopyridoxylation. In contrast to native heparin cofactor II, the modified protease inhibitor did not bind to a heparin-agarose column. The results suggest that lysyl residues are essential for heparin cofactor activity during thrombin inhibition.
D002846:Chromatography, Affinity; D006023:Glycoproteins / Q000032:analysis* / Q000378:metabolism; D015844:Heparin Cofactor II; D006801:Humans; D008239:Lysine / Q000032:analysis*; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D012685:Sepharose / Q000031:analogs & derivatives / Q000378:metabolism; D013053:Spectrophotometry; D013917:Thrombin / Q000494:pharmacology
D006023:Glycoproteins; C037405:heparin-sepharose; D011732:Pyridoxal Phosphate; D015844:Heparin Cofactor II; D012685:Sepharose; D013917:Thrombin; D008239:Lysine